Aim The aim was to assess whether complete mesocolic excision (CME) in patients with right-sided colon cancer is related to short-term mortality or postoperative adverse events requiring reoperation. The complete mobilization of an integral mesocolon and central ligation of blood vessels are essential steps in CME surgery. The resultant specimen, with an intact mesocolic fascia and a high number of harvested lymph nodes, is believed to be oncologically favourable. However, it has been suggested that CME surgery may increase the risk of intra-operative severe adverse events, due to exposure of vital retroperitoneal organs and large blood vessels.
Introduction
Over the last 15-20 years, advancements in imaging techniques, radiotherapy, total mesorectal excision (TME) and the introduction of multidisciplinary team assessments have improved oncological outcomes after rectal cancer treatment [1, 2] . Similar improvements have not been seen for colon cancer during the same time [3] . Therefore, the concept of complete mesocolic excision (CME) has evolved for colon cancer, in analogy to TME for rectal cancer [4] . Essential steps of CME include the complete mobilization of an intact mesocolon and central vascular ligation, resulting in superior specimen quality and a higher number of harvested lymph nodes which is thought to be oncologically favourable [5] [6] [7] . The Stockholm Colon Cancer Project was launched in 2004 and focused on teaching CME surgery, specimen evaluation and multidisciplinary team assessments. The project resulted in improved disease-free and overall survival in patients with right-sided colon cancer [8] . Similar findings have been confirmed by recent publications [9, 10] . However, the observational design of these studies does not provide robust evidence that the improvements rely mainly on CME surgery. In contrast, CME surgery has been suggested to increase the risk of severe adverse intraoperative events, due to exposure of vital retroperitoneal organs such as the duodenum, pancreas and mesenteric root [11, 12] .
The aim of this population-based case-control study was to assess the association between CME surgery and severe adverse events, such as short-term mortality or reoperation, in patients with right-sided colon cancer.
Method
All patients diagnosed with colorectal cancer in Sweden are prospectively registered in a population-based national quality register, the Swedish Colorectal Cancer Registry (SCRCR). Detailed data are reported for each individual patient, including person characteristics, tumour location and stage, neoadjuvant and adjuvant treatments, type of surgery performed and postoperative morbidity and mortality, including reoperations. The registry covers more than 98% of all patients diagnosed with colorectal cancer in Sweden and is linked by a unique personal number to the official Causes of Death Registry.
In 2004, the Stockholm Colorectal Cancer Study Group launched a new educational project with the aim of introducing the CME concept for colon cancer surgery to colorectal surgeons, oncologists, radiologists and pathologists working in the county of Stockholm. Details of the project have been published previously [8] .
Study design
This matched, nested case-control study, with two controls per case, was based on a closed cohort derived from the SCRCR. The original study base consisted of all patients operated for right-sided colon cancer, including the caecum, ascending colon or right colic flexure, in the Stockholm County from 1 January 2004 to 31 December 2012. Patients with metastatic disease, unknown tumour stage or unknown date of surgery, or synchronous colon cancer were excluded from further analysis. Data on the remaining patients were reviewed by one investigator (RB) to identify all patients who died within 90 days after surgery and/or had a reoperation within 30 days after surgery or during the index hospital stay. These patients were defined as cases. Two controls per case, without such an event and individually matched for age, sex, TNM stage and emergent vs elective surgery, were then randomly selected from the cohort. American Society of Anesthesiologists (ASA) score was not routinely registered in SCRCR before 2007 and was therefore missing in 31% of the patients.
Exposure to CME surgery
The exposure status in terms of CME surgery was assessed from original surgical reports, anonymized regarding surgeon names and hospitals. The assessment was done without information on whether the patient was defined as a case or a control. Two investigators, both experienced colorectal surgeons (RB and AS), classified the reports independently per five predefined criteria. The criteria were specified after discussions in the research team and had to be mentioned in the surgical report: (i) dissection of the mesocolon from the duodenum and the head of the pancreas; (ii) visualization of the superior mesenteric vein; (iii) ligation of the ileocolic or right colic vessels at the level of the superior mesenteric vein; (iv) ligation of the right branch of the middle colic vessels at its origin or central ligation of the middle colic vessels; (v) integrity of the mesocolon and the resected bowel segment.
Based on these criteria all surgical reports were labelled by each of the reviewers as 'CME surgery', 'no CME surgery' or 'CME unclear'. Reports classified as CME unclear or with discordance regarding CME status between the two reviewers were reassessed by the two initial investigators and a third colorectal surgeon (CB), all three blinded to the result of the initial assessment. The purpose of the reassessment was to reach consensus or agreement by a majority decision on the binary classification of CME status (CME surgery or no CME surgery).
The possible effects of a learning process concerning the CME technique and hospital volumes were assessed by comparison of three time periods with a similar number of controls operated in each. Also, hospitals that contributed with more than 100 patients were compared to those contributing fewer than 100 patients.
The result of the initial assessment, based on three categories (CME surgery, no CME surgery or CME unclear), was used in a sensitivity analysis of the applied method for classification of CME status.
Bias
The definition of a patient as a case or a control was done without knowledge of exposure status. Exposure was classified independently by two or three reviewers, based on predefined criteria and restricted to the narrative section of the surgical report. The investigators were blinded to additional information of the surgical report such as surgical team, hospital, length of procedure and any other registry data. The data files with patients defined as cases or controls and the classification regarding CME surgery were then merged with registry data on oncological outcomes as a final step in the data analysis.
Statistics
Statistical calculations were done using STATA software (Stata Corp LP, College Station, Texas, USA). Groups were compared with the Wilcoxon rank-sum test (continuous variables) and Fisher's exact test (dichotomous variables). Crude ORs with exact confidence intervals were calculated for the combined outcome (reoperation or short-term mortality) and for both outcomes separately. Conditional logistic regression was used to account for individually matched sets of cases with two controls. The confounding effect of matching variables and ASA was assessed by comparison between basic and adjusted conditional logistic regression models.
The study was approved by the Regional Ethical Review Board.
Results
Patients Figure 1 describes the selection of patients for the study. In all, 2464 patients underwent a bowel resection due to right-sided colon cancer in the Stockholm County between 2004 and 2012. After patient exclusions, as described above, 2070 patients remained. Of these, 240 patients died within 90 days after surgery and/or were reoperated and were included as cases together with 480 individually matched controls. The surgical reports could not be retrieved in four cases and in seven controls.
Clinical characteristics for patients defined as cases or controls are shown in Table 1 resulted in a similar distribution of age, sex, tumour stage and proportions of emergent vs elective procedures among cases and controls. ASA score was available in 69% of the patients. ASA 3-4 was significantly higher among cases than controls: 62.1% vs 42.4% (P < 0.01). Clinical characteristics for the patients in the study are shown in Table S1 , divided into CME vs no CME.
CME surgery
The initial assessment resulted in a CME surgery proportion of 10.5% in cases compared to 14.5% in controls. The proportion of no CME surgery was 72.9% in cases and 68.7% in controls. The CME status was unclear in 16.6% of cases and in 16.9% of controls.
After reassessment of the CME unclear group, a binary CME status was agreed for all 236 cases and 473 controls. The proportion of CME surgery was 14.8% (Table 2) .
Association between CME surgery and severe adverse events
The crude OR for short-term mortality or reoperation following CME surgery was 0.72 (95% CI: 0.47-1.10; P = 0.15) compared to no CME surgery. The separate crude OR for short-term mortality was 0.58 (95% CI: 0.18-1.60; P = 0.37) and for reoperation 0.76 (95% CI: 0.45-1.24; P = 0.29) after CME surgery compared to no CME surgery. The unadjusted conditional logistic regression models confirmed these crude estimates ( Table 3) . The adjusted models showed no evidence for relevant confounding by matching factors or ASA. Table 3 also shows that the OR for short-term mortality or reoperation after CME surgery decreased during the second and third period of the study. Compared to no CME surgery, the OR for short-term mortality or reoperation after CME surgery was lower in hospitals that operated more than 100 patients than in hospitals that operated less than 100 patients. The sensitivity analysis to assess the method for classification of CME status, based on the primary CME classification, showed an OR for short-term mortality or reoperation of 0.71 (0.43-1.18) after CME surgery and an OR of 0.82 (0.58-1.17) after CME unclear, compared to the group classified as no CME surgery.
Discussion
Despite initial criticism, TME is currently accepted as the standard type of resection in rectal cancer surgery. In analogy to the TME concept, CME was introduced by Hohenberger et al. [4] with the aim of improving local control and survival in colon cancer by implementing sharp surgical dissection along embryological planes and central ligation of the supplying arteries. Other authors have used different terminology, such as anatomical dissection of the colon, but the emphasis on precise anatomical dissection to optimize oncological outcomes is similar [5] . Several studies have shown an improved prognosis in colon cancer after CME [10, 13, 14] . However, there has been concern that the more extensive dissection close to retroperitoneal organs and large blood vessels may be hazardous and cause an increased morbidity and mortality [11] . Bertelsen et al. [12] reported that CME surgery was associated with more intra-operative organ injuries than conventional surgery but the 90-day postoperative mortality and rates of postoperative complications were not significantly different. A recent review by Kim et al. [10] did not find any significant differences in short-term outcomes between CME and conventional surgery. Likewise, this population-based case-control study could not demonstrate an increased OR of postoperative death or reoperations in patients having had CME surgery for right-sided colon cancer. In contrast, the OR for these events after CME surgery decreased during the study period. Also, the OR was lower after CME surgery in hospitals with higher volumes than in hospitals with lower volumes.
The reason for selecting patients with right-sided tumours was mainly that the Stockholm Colon Cancer Project focused on right-sided hemicolectomy, but also that this surgery is demanding, with dissection along the head of the pancreas, duodenum and large vessels. In analogy to several other complex surgical procedures, this study suggests a learning curve and a positive relation to patient volumes, with improved results after increasing experience with CME surgery.
To our knowledge, there are no comparable studies based on a priori defined criteria to classify CME surgery from a thorough review of surgical reports. Such classification involves a certain degree of subjectivity based on the readers' own experience. To try to overcome this bias we a priori defined five criteria that all had to be mentioned in the report. Even with this approach surgical reports may lack surgical details that were performed or describe a standard procedure that was not performed in all parts.
Other attempts to improve the validation CME vs no CME have been done by audit of colon cancer specimens and by radiological and pathological evaluation of the level of arterial division [15] [16] [17] [18] .
Most colon cancer resections in Stockholm during the study period were performed by open surgery and the rate of laparoscopic resections was less than 6% with a rather high conversion rate. Although the rate of CME surgery increased during the study period, it was unexpectedly low. There may be several reasons for this, including selection of patients based on age or comorbidity or reluctance by some surgeons to learn and perform a new type of surgery. The low CME rate may also indicate that the criteria to classify an operation as CME were too strict, leading to an underestimation of CME surgery. Thus, there is a risk of misclassification of exposure (CME surgery) in this study. However, this potential misclassification is non-differential as reports were anonymized and merged with other patient and registry data after classification. A non-differential underestimation of exposure results in ORs biased towards no effect of CME surgery which would conceal the full protective effect of CME surgery on severe adverse events. The risk of selection bias, and misclassification, of the defined short-term outcomes is low due to the population-based nature of the study and the high validity of the SCRCR and Cause of Death Registry. The chance to become a control was equal for all patients in the source population and controls were matched for age, sex, tumour stage and urgency of the procedure to enhance the precision with a low risk for overmatching.
The confounding effect of the matching variables and ASA on the adjusted estimates of the conditional logistic regression analysis was small and the reason for reporting the unadjusted estimates.
The fact that the ASA score is missing in 31% is a limitation of the study since ASA score ≥ 2 is an individual risk factor for short-term postoperative morbidity in colon cancer resections [19] . In addition, major non-surgical complications are not reported in this study. The reason is that there is an underreporting of complications in the SCRCR as well as in patient files. This underreporting may differ between different surgeons and hospitals and available data are unreliable. Mortality and reoperations are mandatory to report and reliable and are therefore included in the study. It is also likely that major non-surgical complications would result in increased 90-day mortality.
In conclusion, CME for right-sided colon cancer does not appear to be associated with an increased risk of 90-day mortality or reoperation. A trend towards a protective effect of CME surgery on short-term outcomes was observed, which might be expected with increasing experience, especially in hospitals with a sufficient caseload.
Supporting Information
Additional Supporting Information may be found in the online version of this article: Table S1 . Clinical characteristics for CME vs no CME.
Commentary on 'Complete mesocolic excision (CME) in right sided colon cancer does not increase severe short term postoperative adverse events'
We have reached more or less consensus about the meaning of total mesorectal excision (TME) in rectal cancer surgery during the past four decades. More recently the concept of complete mesocolic excision (CME) was introduced for colon cancer surgery. Although the concept of CME is actually identical to TME, there is much more controversy about the definition of CME. Is this because of the difference between the words 'complete' and 'total', or is it something else than an agentive discussion?
In rectal cancer, TME does not per se include resection of the most central or apical lymph nodes. The extensiveness of the lymphadenectomy in rectal cancer is still a matter of debate, but we all agree on the importance of respecting the embryological planes, and that a TME specimen should have an intact mesorectal fascia. Not all colorectal surgeons dissect the most central lymph nodes from the origin of the inferior mesenteric artery as a routine, as there is no conclusive evidence that this will have a survival benefit. However, we do observe isolated recurrences in these apical nodes, for which reason others routinely perform a D3 lymphadenectomy, either with ligation of the inferior mesenteric artery ('high tie') or the superior rectal artery ('low tie') [1] . In summary, TME surgery can be sub classified as TME D2 or TME D3 depending on the extent of lymphadenectomy.
In colon cancer, CME is often associated with extensive lymphadenectomy, sometimes even including lymph nodes along the greater curvature of the stomach or pancreatic tail. This can be questioned, as there is no strong, conclusive evidence this improves oncological outcomes. Should we not separate the concept of CME from the extensiveness of the lymphadenectomy, as we do in rectal cancer? CME encompasses dissection of the mesocolon from the retroperitoneum along the socalled meso-fascial interface, which should produce a nice intact specimen without any breach of its surface [2] . Similar to rectal cancer, we should then define the level of lymphadenectomy: CME D2 or CME D3.
The basic difference between the vascularization of the rectosigmoid and the colon from the perspective of lymphadenectomy is that a high tie of the superior mesenteric artery is not compatible with life, while a high tie of the inferior mesenteric artery does not devascularize the remaining bowel. Central vascular ligation (CVL) is a confusing term, because resection of apical nodes does not necessarily require a 'high tie' [1] . Secondly, dissection of the apical nodes at the level of the superior mesenteric artery is complicated by the presence of the superior mesenteric vein, while the inferior mesenteric vein can be sacrificed without major consequences. Both vessels have autonomic nerves in their close vicinity, even though the clinical implications of doi:10.1111/codi.13961
